GLAXO PROFITS SHARPLY DIVIDEND RAISED months endDecember Shr 326p 223p Div 50p 40p Pretax profit 376 mln stg 260 mln Turnover 883 mln 686 mln Tax 133 mln 94 mln Note  company full Glaxo Holdings Plc ltGLXOL Trading profit 338 mln 233 mln Share profits associates 14 mln mln Investment income interest payable 24 mln 20 mln Profit tax 243 mln 166 mln Minority interests mln mln Extraordianry credit mln nil Turnover includes  Continuing activities 875 mln 647 mln Discontinued activities mln 39 mln UK 111 mln 91 mln Europe 299 mln 218 mln North America 334 mln 229 mln Central South America 21 mln 20 mln Africa Middle East 29 mln 23 mln South East Asia East 57 mln 47 mln Australasia 24 mln 19 mln Antipeptic ulcerants 414 mln 285 mln Systemic antibiotics 112 mln 82 mln Respiratory system 183 mln 141 mln